author-photo

Detlev Haehling

Leipzig University

11

Papers

27

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)

2016 Journal of Cancer Research and Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Higher Incidence of Secondary AML and Adverse Molecular Markers, Together with Lower CR and Higher AML Related Death Rates in Elderly Compared to Younger Patients: Results from 2435 Patients Included in the Two German AML Intergroup Studies

2015 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Increasing The Dose Of AraC In Consolidation Therapy Does Not Lead To Higher Overall Survival Or Improved Relapse Incidence In Patients With AML Over The Age Of 60 Years

2013 Blood
Show All
- Source
- Cite
- Save
Citations (1)
High CR-Rate after Intensive Chemotherapy but Disappointing Results after Palliative Treatment in Patients with Acute Myeloid Leukemia Above the Age of 60 Years: An Analysis of the AML97#38 Study of the East German Hematology and Oncology Study Group (OSHO).

2007 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Early Allogenic Transplantation Improves Overall Survival (OS) and Event Free Survival (EFS) Independently of the Applied Chemotherapy in AML Patients with Unfavourable Cytogenetic Karyotype.

2006 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Cost Evaluation of Rituximab Plus MCP vs. MCP Alone in Advanced Stage Indolent Non-Hodgkin’s-Lymphoma Based on a Randomized Controlled Multicenter Trial.

2004 Blood
Show All
- Source
- Cite
- Save
Citations (4)